timef 01/01/2026
- Novo Nordisk enters 2026 on the defense as it faces a ‘must-win’ battle in the U.S. market cnbc.com2026-01-01 14:00:01
The FDA approval of the Wegovy pill highlights many of the key themes Novo Nordisk will have to face in 2026.
- Google wraps up best year on Wall Street since 2009, beating megacap peers as AI story strengthens cnbc.com2026-01-01 05:06:31
Shares of Alphabet rallied in 2025 as the company responded to skepticism of its position in artificial intelligence with new products that excited investors.
